Clinical Trial

Arrhythmic Risk in Myocarditis Outcome Research

Study acronym: ARMOR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational, retrospective, multicenter study is to characterize the arrhythmic burden and identify predictive factors for ventricular arrhythmias (VAs) in adult patients hospitalized for acute myocarditis (AM). The main questions it aims to answer are: * What is the incidence of sustained ventricular arrhythmias during the index hospitalization in patients with acute myocarditis? * What clinical, biological, electrocardiographic, and imaging factors predict the occurrence of sustained ventricular arrhythmias during hospitalization and after discharge? Researchers will compare patients who developed sustained VAs during hospitalization to those who did not, in order to identify independent predictors of arrhythmic events and develop a validated risk stratification score. Participants' medical records from 2020 to 2024 will be reviewed to collect: * Baseline demographic, clinical, biological, electrocardiographic, and imaging data at admission * In-hospital management strategies and outcomes, including mortality, cardiogenic shock, and heart replacement therapy * Long-term follow-up data including VA recurrence, sudden cardiac death, and development of cardiomyopathy, with censoring applied on January 1, 2026
Trial Details
NCT Number NCT07501481
Lead Sponsor AZ Sint-Jan AV
Collaborators: University Hospital, Toulouse, Rennes University Hospital, University Hospital, Montpellier, University Hospital, Bordeaux, Institut universitaire de cardiologie et de pneumologie de Québec, University Laval, Poitiers University Hospital
Conditions Myocarditis Acute, Ventricular Arrhythmia
Enrollment 1,500 participants
Start Date 2026-03-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-30